Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05039476
Other study ID # 20218Chemist
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2022
Est. completion date November 30, 2022

Study information

Verified date February 2023
Source Chemist Confessions, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chemist Confessions has developed a retinol cream with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, hyperpigmentation, and crow's feet. In this phase, Chemist Confessions plans to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet.


Description:

Based on a review of existing literature and previous studies, retinol has been found to have positive effects, however, due to study limitations, there are also conflicting results. Therefore, in this study, participants will receive Chemist Confessions retinol cream to understand if the Chemist Confessions cream has an impact on the participant's skin, and even potentially reduces fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet of the skin, and also to understand concepts considered essential by individuals taking retinol products.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date November 30, 2022
Est. primary completion date November 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria: - Female between 30-50 years old - Must be in good general health - Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication - May experience hyperpigmentation, dark spots and dark circles - Must maintain the following skincare routine containing: cleansing, allowed moisturizer and study specific sunscreen - Must use study provided sunscreen daily - Must discontinue the use of other retinoids 4 weeks before the study start date - Must have some general knowledge of retinoid use - Must be willing to comply with the requirements of the protocol - Must be able to communicate in English - Must be able to tell left from right - Must willing to add the retinoid cream to their skincare routine - Must provide written informed consent form (ICF) - Is willing and able to share feedback and take skin pictures via the used technology portal - Must be willing to refrain from using products with chemical exfoliants glycolic acid and lactic acid during the duration of the study Exclusion Criteria: - Unwilling to provide consent - Unwilling to add the retinoid cream to their normal skincare routine - Unwilling to follow the routine of the protocol - Uses moisturizers that include chemical exfoliating ingredients such as glycolic acid, lactic acid or salicylic acid - Use of other oral retinoids - Use of prescription medication relevant to the skin - Undergoing any cosmetic procedures during the study including Botox, laser or chemical peel treatments - Deep-set of wrinkles - Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (for example retinoids) - Is pregnant or nursing, or attempting a pregnancy - Used retinoids before with an adverse reaction - Has a self-identified sensitive skin type - Has any learning and/or cognitive difficulties that prevent him/her reading and understanding questionnaires and surveys (e.g. dementia)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Retinol face cream
Retinol face cream
Placebo face cream
Placebo face cream

Locations

Country Name City State
United States Citruslabs Santa Monica California

Sponsors (2)

Lead Sponsor Collaborator
Chemist Confessions, Inc. Citruslabs

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of skin appearance of early signs of aging The primary objective of this study is to understand if Chemist Confessions retinol cream is capable of improving the appearance of early signs of aging such as fine lines, dark spots, wrinkles, hyperpigmentation and crow's feet, and to determine if it helps to improve the overall skin health by promoting hydrated, brightened skin for study participants.
To evaluate the improvement of this outcome measure VISIA imaging will be used.
12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A